Publications
By Year
Now showing items 5381-5385 of 5385 records
Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial
Butler, J; Müller, K; Shah, SJ; Roessig, L; Lam, CS; Greene, SJ; Samano, ET; SOCRATES-REDUCED Investigators and Coordinators; Pieske, B; Ponikowski, P; Solomon, SD; Maggioni, AP; Filippatos, G; Gheorghiade, M; Kraigher-Krainer, E
JAMA - 01 Dec 2015
IMPORTANCE: Worsening chronic heart failure (HF) is a major public health problem. OBJECTIVE: To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left ventricular ejection fraction (LVEF). DESIGN, SETTING, AND PARTICIPANTS: Dose-finding phase 2 study that randomized 456 patients across...
Effect of finerenone on albuminuria in patients with diabetic nephropathy a randomized clinical trial
Bakris, GL; Chan, JC; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group; Schmieder, RE; Cooper, ME; Nowack, C; Kimmeskamp-Kirschbaum, N; Rossing, P; Gansevoort, RT; Kolkhof, P; Pieper, A; Remuzzi, G; Haller, H; Agarwal, R; Joseph, A; Ruilope, LM
JAMA - 01 Sep 2015
IMPORTANCE: Steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with chronic kidney disease but may be underused because of a high risk of adverse events. OBJECTIVE: To evaluate the safety and efficacy of different oral doses of the nonsteroidal mineralocorticoid receptor antagonist finerenone, given f...
Glycated hemoglobin measurement and prediction of cardiovascular disease
Gao, P; Khan, H; Kaptoge, S et al.; Di Angelantonio, E; Butterworth, AS; Wormser, D
JAMA - 26 Mar 2014
IMPORTANCE: The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE: To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS: Analysis of individual-par...
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial
Walker, PJ; Askew, C; Ahimastos, AA; Reid, CM; Kingwell, BA; Leicht, A; Pappas, E; Blombery, P
JAMA - 06 Feb 2013
IMPORTANCE: Approximately one-third of patients with peripheral artery disease experience intermittent claudication, with consequent loss of quality of life. OBJECTIVE: To determine the efficacy of ramipril for improving walking ability, patient-perceived walking performance, and quality of life in patients with claudication. DESIGN, SETTING, AND PATIENTS: Randomized, double-blind, placebo-co...
Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial
Lambert, G; Naughton, MT; Jones, K; Bailey, M; O'Brien, PE; Grima, M; Schachter, LM; Dixon, JB; Brown, W
JAMA - 19 Sep 2012
CONTEXT: Obstructive sleep apnea (OSA) is strongly related to obesity. Weight loss is recommended as part of the overall management plan for obese patients diagnosed with OSA. OBJECTIVE: To determine whether surgically induced weight loss is more effective than conventional weight loss therapy in the management of OSA. DESIGN, SETTING, AND PATIENTS: A randomized controlled trial of 60 obe...